By Cliff Rold - Lamont Peterson. Andre Berto. Erik Morales.
Lamont Peterson-Amir Khan II: off.
Victor Ortiz-Andre Berto II: off
Danny Garcia-Erik Morales II: if at first you don’t test clean, try and try again. The show must go on.
Welcome to boxing in 2012 as the performance enhancing drug (P.E.D.) issue struck like a Barry Bonds shot into the drink with results that illuminated and indicted the game in ways that had been avoided for far too long. Positive tests, journalist/promoter feuds, accusations, insinuations, politics, and mountains of evidence both real and circumstantial: it was the story that kept on giving.
The runaway choice at BoxingScene for 2012 event of the year was clear: P.E.D.rama reigned.
Let’s unbury any heads left in the sand. P.E.D. use isn’t new in boxing. There are rumors about big name fighters, and around big fights, dating back at least two decades. That doesn’t include the verified incidents.
Roy Jones-Richard Hall had both fighters test positive on initial samples in 2000.
Fernando Vargas was busted after his 2002 defeat to Oscar De La Hoya. Shane Mosley tested clean but was later found to have used before his Oscar De La Hoya rematch in 2003. Orlando Salido lost a win over Robert Guerrero in 2006 when he tested positive.
Boxing’s lack of real governance made it easy to isolate the incidents and move along. Token suspensions and fines were levied and then Floyd Mayweather kicked off a new direction. His insistence in negotiations with Manny Pacquiao in 2009/10 for what was incorrectly described as Olympic style testing (it wouldn’t have been all year random) set the stage. The US Anti-Doping Agency (USADA)/Voluntary Anti-Doping Agency (VADA) debate of 2012 was one element of an evolving specter. [Click Here To Read More